|
Market Closed -
Other stock markets
|
After hours 00:59:31 | |||
| 182.00 USD | +4.33% |
|
182.73 | +0.40% |
| 01-16 | President Capital Management Initiates Coverage on Astera Labs With Buy Rating | MT |
| 01-15 | RBC Initiates Astera Labs at Outperform With $225 Price Target | MT |
| Capitalization | 30.74B 26.5B 24.67B 22.97B 42.76B 2,789B 46.01B 284B 112B 1,330B 115B 113B 4,858B | P/E ratio 2025 * |
144x | P/E ratio 2026 * | 107x |
|---|---|---|---|---|---|
| Enterprise value | 29.95B 25.82B 24.03B 22.37B 41.66B 2,717B 44.82B 276B 109B 1,296B 112B 110B 4,732B | EV / Sales 2025 * |
36.2x | EV / Sales 2026 * | 25x |
| Free-Float |
83.24% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Astera Labs, Inc.
| 1 day | +0.40% | ||
| 1 week | +11.92% | ||
| Current month | +9.40% | ||
| 1 month | +25.57% | ||
| 3 months | +11.28% | ||
| 6 months | +97.96% | ||
| Current year | +9.40% |
| 1 week | 160.25 |  | 188 |
| 1 month | 143.68 | | 188 |
| Current year | 151.1 | | 188 |
| 1 year | 47.12 | | 262.9 |
| 3 years | 36.22 | | 262.9 |
| 5 years | 36.22 | | 262.9 |
| 10 years | 36.22 | | 262.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Gajendra
PSD | President | 52 | 31/10/2023 |
Casey Morrison
PRN | Corporate Officer/Principal | - | 30/09/2017 |
Jitendra Mohan
CEO | Chief Executive Officer | 52 | 31/10/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Jitendra Mohan
BRD | Director/Board Member | 52 | 31/10/2017 |
Jack Lazar
BRD | Director/Board Member | 60 | 07/12/2022 |
| Director/Board Member | 53 | 31/10/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.33% | +11.92% | +42.30% | - | 30.74B | |
| -0.44% | +0.74% | +39.43% | +1,002.02% | 4,525B | |
| +2.53% | +1.95% | +53.31% | +507.44% | 1,668B | |
| +2.96% | +3.57% | +57.47% | +244.55% | 1,427B | |
| +7.76% | +5.12% | +253.56% | +537.19% | 408B | |
| +1.72% | +14.11% | +95.74% | +226.52% | 377B | |
| +0.93% | +1.61% | +260.00% | +781.12% | 354B | |
| -2.81% | +3.10% | +138.74% | +55.96% | 234B | |
| +1.30% | +0.67% | +2.25% | +7.02% | 174B | |
| -1.22% | -10.33% | -1.25% | +32.58% | 169B | |
| Average | +1.41% | +3.12% | +94.15% | +377.16% | 936.81B | |
| Weighted average by Cap. | +0.88% | +1.92% | +65.65% | +678.01% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 828M 714M 664M 618M 1.15B 75.1B 1.24B 7.64B 3.01B 35.82B 3.1B 3.04B 131B | 1.18B 1.02B 946M 880M 1.64B 107B 1.76B 10.88B 4.29B 50.99B 4.42B 4.33B 186B |
| Net income | 220M 190M 177M 164M 306M 19.97B 329M 2.03B 801M 9.53B 825M 808M 34.78B | 294M 253M 236M 219M 408M 26.64B 439M 2.71B 1.07B 12.71B 1.1B 1.08B 46.39B |
| Net Debt | -795M -686M -638M -594M -1.11B -72.17B -1.19B -7.34B -2.9B -34.42B -2.98B -2.92B -126B | -1.28B -1.11B -1.03B -959M -1.79B -116B -1.92B -11.85B -4.67B -55.55B -4.81B -4.71B -203B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 182.00 $ | +4.33% | 5,422,777 |
| 15/01/26 | 174.45 $ | +1.34% | 3,906,835 |
| 14/01/26 | 172.14 $ | -4.66% | 3,622,807 |
| 13/01/26 | 180.56 $ | +4.63% | 4,457,103 |
| 12/01/26 | 172.57 $ | +6.13% | 4,439,129 |
Delayed Quote Nasdaq, January 16, 2026 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ALAB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition